Neuromodulation alters nerve activity by delivering electrical or pharmaceutical agents directly to a target area. This feed focuses on different types of light therapies and methods, including optogenetics and low-level laser applications.

January 14, 2021

Advances in Implantable Microelectrode Array Insertion and Positioning

Neuromodulation : Journal of the International Neuromodulation Society
David AtkinsonJoseph J Pancrazio
January 9, 2021
Open Access

Autonomic Modulation for Cardiovascular Disease

Frontiers in Physiology
Joseph Hadaya, Jeffrey L Ardell
January 9, 2021
Open Access

Lightening the Perceived Prosthesis Weight with Neural Embodiment Promoted by Sensory Feedback

Current Biology : CB
Greta PreatoniStanisa Raspopovic
January 14, 2021
Open Access

Multichannel optogenetics combined with laminar recordings for ultra-controlled neuronal interrogation

BioRxiv : the Preprint Server for Biology
D. ErikssonIlka Diester
January 12, 2021
Open Access

Focused Ultrasound Induced Blood-Brain Barrier Opening for Targeting Brain Structures and Evaluating Chemogenetic Neuromodulation

Journal of Visualized Experiments : JoVE
Jerzy O Szablowski, Manwal Harb
January 10, 2021

Distinct functions of ventral CA1 and dorsal CA2 in social memory

Current Opinion in Neurobiology
Akiyuki WataraiTeruhiro Okuyama
January 9, 2021

Explant rates of neuromodulation devices: supplemental information-reply to Mukhdomi and Harris

Regional Anesthesia and Pain Medicine
Adnan Al-KaisyStephen Ward
January 9, 2021

Effects of Chronic Photobiomodulation with Transcranial Near-Infrared Laser on Brain Metabolomics of Young and Aged Rats

Molecular Neurobiology
Fabrízio Dos Santos CardosoSérgio Gomes da Silva
January 9, 2021

Anterior cingulate inputs to nucleus accumbens control the social transfer of pain and analgesia

Monique L SmithRobert C Malenka
January 10, 2021
Open Access

Organ-specific, multimodal, wireless optoelectronics for high-throughput phenotyping of peripheral neural pathways

Nature Communications
Woo Seok KimSung Il Park
January 15, 2021
Open Access

Astrocyte-secreted IL-33 mediates homeostatic synaptic plasticity in the adult hippocampus

Proceedings of the National Academy of Sciences of the United States of America
Ye WangNancy Y Ip
January 11, 2021
Open Access

Understanding and treating paediatric hearing impairment

Christian WrobelTobias Moser
January 11, 2021

Functional Characterization of Nociceptive Mechanisms Involved in Fibromyalgia and Electroacupuncture

Brain Research
Bernice Lottering, Yi-Wen Lin
January 14, 2021

Ethical Considerations in the Implantation of Neuromodulatory Devices

Neuromodulation : Journal of the International Neuromodulation Society
Nathan A Shlobin, Joshua M Rosenow
January 12, 2021
Open Access

Switching of delta opioid receptor subtypes in central amygdala microcircuits is associated with anxiety states in pain

The Journal of Biological Chemistry
Wenjie ZhouWenjuan Tao
January 9, 2021
Open Access

AgRP neurons trigger long-term potentiation and facilitate food seeking

Translational Psychiatry
Chunmei WangYong Xu

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved